BNR

Burning Rock Biotech Limited (BNR) SWOT Analysis Analysis (2026)

Invetso Score: 3.6/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.8 (Moderate)

Current ratio of 3.1 and quick ratio of 2.8 indicate liquidity well above many peers, reducing near-term refinancing pressure despite weak profitability.

Debt-to-equity of 0.10 suggests modest balance-sheet leverage versus more indebted peers, which preserves financial flexibility even though net debt remains elevated.

The company’s working-capital cushion can support operations through demand volatility better than peers with tighter liquidity, partially offsetting its negative return profile.

Weaknesses

Score:

ROIC of -10.1% shows capital is not earning its cost, leaving BNR structurally behind profitable peers on value creation.

Net debt to EBITDA of 17.1 signals a highly stretched leverage burden versus peers, constraining strategic flexibility and amplifying earnings sensitivity.

Cash conversion cycle of 226.8 days indicates slow cash recovery relative to peers, tying up working capital and pressuring free-cash generation.

The combination of weak returns and slow cash conversion suggests operational inefficiency versus peers, limiting margin resilience and reinvestment capacity.

Opportunities

Score:

If BNR shortens its 226.8-day cash conversion cycle, it could release working capital faster than peers and improve liquidity without external funding.

With low debt-to-equity, the company has more room than highly levered peers to fund operational improvements or selective growth initiatives.

Peer gaps in capital efficiency create upside if management converts balance-sheet flexibility into higher returns, though the current data do not show that progress.

Threats

Score:

A 17.1 net debt-to-EBITDA ratio leaves BNR more exposed than peers to higher rates or weaker demand, because refinancing risk rises as earnings stay pressured.

Negative ROIC increases the risk that competitors with better capital discipline will outcompete BNR on pricing, investment, and market share over time.

The long cash conversion cycle can worsen under peer-driven pricing pressure, because slower collections and inventory turns reduce operating headroom.

If peers sustain stronger returns and faster cash generation, BNR’s relative positioning may deteriorate further as capital markets reward more efficient operators.

Overall Score

Score:

BNR’s liquidity is a relative strength, but negative returns, very high leverage, and slow cash conversion leave its structural positioning weaker than most peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Burning Rock Biotech Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →